Literature DB >> 3340078

Chronic morphine treatment increases cyclic AMP-dependent protein kinase activity in the rat locus coeruleus.

E J Nestler1, J F Tallman.   

Abstract

We have studied a possible role for cyclic AMP-dependent protein kinase in mediating opiate addiction in the central nervous system by focusing on the rat locus coeruleus. This brain region is well suited for these studies because it is relatively homogeneous and because a wealth of electrophysiological and behavioral data indicate that it plays an important role in mediating the chronic effects of opiates in animals, including humans. It was found that chronic, but not acute, in vivo treatment of rats with morphine increased cyclic AMP-dependent protein kinase activity in the locus coeruleus with a time course that closely paralleled the time course by which locus coeruleus neurons become tolerant to and dependent on opiates, based on electrophysiological studies. Concomitant administration of the opiate receptor antagonist naltrexone was found to block the effect of chronic morphine treatment on protein kinase activity, indicating that the effect is mediated via specific activation of opiate receptors. In contrast, chronic morphine treatment did not alter protein kinase activity in several other brain regions studied, including the neostriatum, frontal cortex, and dorsal raphe. We propose that the observed increase in cyclic AMP-dependent protein kinase activity in the locus coeruleus contributes to the biochemical basis of opiate addiction.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3340078

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  39 in total

1.  Reciprocal modulation of phospholipase Cbeta isoforms: adaptation to chronic morphine.

Authors:  Sumita Chakrabarti; Nai-Jiang Liu; Alan R Gintzler
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-03       Impact factor: 11.205

2.  CREB (cAMP response element-binding protein) in the locus coeruleus: biochemical, physiological, and behavioral evidence for a role in opiate dependence.

Authors:  S B Lane-Ladd; J Pineda; V A Boundy; T Pfeuffer; J Krupinski; G K Aghajanian; E J Nestler
Journal:  J Neurosci       Date:  1997-10-15       Impact factor: 6.167

3.  Prolonged Morphine Treatment Alters Expression and Plasma Membrane Distribution of β-Adrenergic Receptors and Some Other Components of Their Signaling System in Rat Cerebral Cortex.

Authors:  Lucie Hejnova; Jitka Skrabalova; Jiri Novotny
Journal:  J Mol Neurosci       Date:  2017-10-28       Impact factor: 3.444

Review 4.  Pathophysiology of opioid tolerance and clinical approach to the opioid-tolerant patient.

Authors:  O de Leon-Casasola; A Yarussi
Journal:  Curr Rev Pain       Date:  2000

Review 5.  The molecular biology of addictive drugs.

Authors:  S A Mackler; J H Eberwine
Journal:  Mol Neurobiol       Date:  1991       Impact factor: 5.590

6.  Opposite modulation of opiate withdrawal behaviors on microinfusion of a protein kinase A inhibitor versus activator into the locus coeruleus or periaqueductal gray.

Authors:  L J Punch; D W Self; E J Nestler; J R Taylor
Journal:  J Neurosci       Date:  1997-11-01       Impact factor: 6.167

7.  Increased probability of GABA release during withdrawal from morphine.

Authors:  A Bonci; J T Williams
Journal:  J Neurosci       Date:  1997-01-15       Impact factor: 6.167

8.  Alterations in brain metabolism induced by chronic morphine treatment: NMR studies in rat CNS.

Authors:  Sushil K Sharma; Kiran Yashpal; Marian E Fundytus; Françoise Sauriol; James L Henry; Terence J Coderre
Journal:  Neurochem Res       Date:  2003-09       Impact factor: 3.996

9.  Role of protein kinase C in desensitization of spinal delta-opioid-mediated antinociception in the mouse.

Authors:  M Narita; H Mizoguchi; J P Kampine; L F Tseng
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

10.  Differential desensitization of mu- and delta- opioid receptors in selected neural pathways following chronic morphine treatment.

Authors:  F Noble; B M Cox
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.